Shots: The approval is based on data from the SYNAPSE study evaluating mepolizumab vs PBO in ~400 patients with CRSwNP who had a history of prior surgery & need further […]readmore
Tags : Chronic Rhinosinusitis
Shots: The Health Canada has approved a new indication as an add-on maintenance treatment with intranasal corticosteroids in patients with CRSwNP, inadequately controlled by systemic corticosteroids or surgery The approval […]readmore
Shots: The approval is based on two SINUS-24 & SINUS-52 studies results assessing Dupixent (300mg, q2w) + mometasone furoate nasal spray (MFNS) vs PBO + MFNS in patients with CRSwNP […]readmore
Shots: The P-III POLYP 1 & POLYP 2 studies results involve assessing of Xolair (SC, q2w/q4w) vs PBO in 138 & 127 patients with CRSwNP with inadequate response to intranasal […]readmore